tiprankstipranks
Vaxart completes enrollment  in Phase 2b study evaluating its COVID-19 pill
PremiumThe FlyVaxart completes enrollment in Phase 2b study evaluating its COVID-19 pill
2M ago
Vaxart reports inducement grants under Nasdaq listing rule
Premium
The Fly
Vaxart reports inducement grants under Nasdaq listing rule
2M ago
Vaxart’s Q3 2024: Progress in Oral Vaccine Development
Premium
Company Announcements
Vaxart’s Q3 2024: Progress in Oral Vaccine Development
3M ago
Vaxart will present research on COVID-19, norovirus vaccine candidates
PremiumThe FlyVaxart will present research on COVID-19, norovirus vaccine candidates
3M ago
Vaxart to present norovirus data at IDWeek 2024
Premium
The Fly
Vaxart to present norovirus data at IDWeek 2024
4M ago
Vaxart Ends Sales Agreement, Halts Stock Offering
Premium
Company Announcements
Vaxart Ends Sales Agreement, Halts Stock Offering
4M ago
Vaxart rallies 6% to 63c after bullish Opco initiation with $4 target
PremiumThe FlyVaxart rallies 6% to 63c after bullish Opco initiation with $4 target
6M ago
Vaxart initiated with an Outperform at Oppenheimer
Premium
The Fly
Vaxart initiated with an Outperform at Oppenheimer
6M ago
Vaxart reports Q2 EPS (9c), consensus (3c)
Premium
The Fly
Vaxart reports Q2 EPS (9c), consensus (3c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100